Results 171 to 180 of about 4,769 (189)

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Artur Oreziak, Roberto Barriales Villa, Theodore P Abraham   +2 more
exaly  

Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy

Circulation, 2021
Sara Ranjbarvaziri, Mathew Ellenberger, Giovanni Fajardo   +2 more
exaly  

Hypertrophic scarring: the greatest unmet challenge after burn injury

Lancet, The, 2016
Celeste C Finnerty, Marc G Jeschke, Joan-pere Barret Nerín   +2 more
exaly  

Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry

Lancet, The, 2013
James Dean Wilkinson, Lynn A Sleeper, Daphne T Hsu   +2 more
exaly  

Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy

Lancet, The, 2000
Ali J Marian
exaly  

Hypertrophic obstructive cardiomyopathy

Lancet, The, 2017
Josef Veselka, Philippe Charron
exaly  

Hypertrophic cardiomyopathy

Lancet, The, 2013
exaly   +2 more sources

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy

Circulation, 2018
Carolyn Y Ho, Sharlene M Day, Michelle Michels   +2 more
exaly  

[Keloid versus hypertrophic cicatrix].

Revista brasileira de cirurgia, 1966
openaire   +1 more source

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Lancet, The, 2001
Perry M Elliott, Niall G Mahon
exaly